Drugs / Autologous Serum Therapy
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06816784 Comparator | Feb → Jul 2025 overdue | chronic urticaria | Sheikh Zayed Medical College | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Serum Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06816784 ↗ |
| Known as | AST | “Our study aim to compare the efficacy of Autologous Serum Therapy (AST) with levocetirizine in Chronic Urticaria patients” NCT06816784 ↗ |
| Route | Intramuscular | “2 ml of the serum will be injected into the gluteus muscle” NCT06816784 ↗ |